A. R. Richens

A. R. Richens's AcademicInfluence.com Rankings

A. R. Richens

Medical

#1797

World Rank

#2173

Historical Rank

Neurology

#161

World Rank

#230

Historical Rank

medical Degrees

A. R. Richens

Biology

#7188

World Rank

#10069

Historical Rank

Neuroscience

#902

World Rank

#938

Historical Rank

biology Degrees

Download Badge

Medical
Biology

A. R. Richens's Degrees

Bachelors Neuroscience University of Oxford

Why Is A. R. Richens Influential?

(Suggest an Edit or Addition)

(See a Problem?)

A. R. Richens's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy (1995) (581)
Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy (1970) (390)
Disturbance of Calcium Metabolism by Anticonvulsant Drugs (1970) (356)
Lamotrigine‐Associated Rash: Risk/Benefit Considerations in Adults and Children (1999) (305)
Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. (1997) (256)
Clinical Pharmacokinetics of Phenytoin (1979) (230)
The Efficacy of Valproate‐Lamotrigine Comedication in Refractory Complex Partial Seizures: Evidence for a Pharmacodynamic Interaction (1999) (223)
A Textbook of Epilepsy (1993) (200)
Controlled Trial of Lamotrigine (Lamictar) for Refractory Partial Seizures (1989) (195)
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. (1984) (192)
SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSY (1975) (185)
A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. (1994) (179)
DOUBLE-BLIND STUDY OF γ-VINYL GABA IN PATIENTS WITH REFRACTORY EPILEPSY (1984) (173)
Letter: Thymoxamine and spasticity. (1974) (169)
Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract. (1987) (154)
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. (1995) (151)
Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy (1987) (126)
The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. (1980) (124)
Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop (2003) (124)
Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data (1983) (120)
Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome. (1992) (117)
Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance. (1984) (117)
Safety of Lamotrigine (1994) (108)
Interaction of lamotrigine with sodium valproate (1993) (106)
Effect of Norethisterone on Seizures Associated with Menstruation (1983) (98)
Letter: Epilepsy and driving. (1974) (93)
Interaction between vigabatrin and phenytoin. (1989) (89)
Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trial (1995) (88)
Oral phenytoin pharmacokinetics during omeprazole therapy. (1987) (87)
Epilepsy and Driving (1967) (86)
Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. (1979) (81)
An Update on Sodium Valproate (1985) (80)
Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients. (1975) (77)
Reduction of free testosterone by antiepileptic drugs. (1982) (76)
Overview of the Clinical Efficacy of Lamotrigine (1991) (74)
Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. (1984) (72)
The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine (1991) (71)
Plasma protein binding interaction between phenytoin and valproic acid in vitro. (1978) (71)
A pharmacodynamic evaluation of midazolam as an antiepileptic compound. (1986) (70)
Clobazam as adjunctive treatment in refractory epilepsy. (1983) (70)
Predicting Phenytoin Dose—A Revised Nomogram (1979) (68)
Controlled trial of sodium valproate in severe epilepsy. (1975) (66)
Water intoxication in epileptic patients receiving carbamazepine. (1978) (65)
The effect of lamotrigine, a novel anticonvulsant, on interictal spikes in patients with epilepsy. (1986) (65)
PITUITARY RESPONSIVENESS TO GONADOTROPHIN‐RELEASING AND THYROTROPHIN‐RELEASING HORMONES IN EPILEPTIC PATIENTS RECEIVING CARBAMAZEPINE OR PHENYTOIN (1984) (65)
Juvenile myoclonic epilepsy. (1992) (63)
Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy. (1982) (61)
Antiepileptic therapy : advances in drug monitoring (1980) (61)
Linkage analysis of juvenile myoclonic epilepsy and microsatellite loci spanning 61 cM of human chromosome 6p in 19 nuclear pedigrees provides no evidence for a susceptibility locus in this region. (1996) (60)
Metoprolol and propranolol in essential tremor: a double-blind, controlled study. (1981) (59)
Absorption of Diazepam from the Rectum and Its Effect on Interictal Spikes in the EEG (1982) (54)
Involuntary movements caused by phenytoin intoxication in epileptic patients. (1975) (54)
Rate of entrance of benzodiazepines into the brain determined by eye movement recording. (1983) (54)
Attitudes of GPs to the care of people with epilepsy. (1998) (54)
Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam. (1986) (54)
The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration. (1983) (54)
Rate of elimination of tracer doses of phenytoin at different steady-state serum phenytoin concentrations in epileptic patients. (1974) (53)
Evaluation of the positional candidate gene CHRNA7 at the juvenile myoclonic epilepsy locus (EJM2) on chromosome 15q13–14 (2002) (52)
Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients. (1979) (50)
Pharmacology and Clinical Pharmacology of Vigabatrin (1991) (50)
Anticonvulsant effects of extracts of the west African black pepper, Piper guineense. (1993) (49)
Inhibition of phenytoin metabolism by sulthiame in epileptic patients. (1974) (49)
Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients. (1982) (48)
Effect of single doses of sodium valproate on serum phenytoin level and protein binding in epileptic petients (1980) (47)
Phenylethylmalonamide in essential tremor. A double-blind controlled study. (1981) (47)
Lamotrigine in primary generalised epilepsy (1992) (47)
Valproic acid and diazepam interaction in vivo. (1982) (47)
A Study of the Pharmacokinetics of Phenytoin (Diphenylhydantoin) in Epileptic Patients, and the Development of a Nomogram for Making Dose Increments (1975) (46)
The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment. (1985) (46)
The effect of vigabatrin on brain and platelet GABA-transaminase activities. (1989) (46)
Altered Drug Binding to Serum Proteins in Pregnant Women: Therapeutic Relevance (1981) (44)
Lack of hepatic enzyme inducing effect of sodium valproate. (1979) (44)
Effect of a single oral dose of propranolol on essential tremor: A double‐blind controlled study (1983) (43)
Interaction between phenytoin and imipramine. (1977) (43)
Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind, placebo controlled study in healthy volunteers. (1993) (43)
Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin. (1987) (43)
A clinical trial of single dose rectal and oral administration of diazepam for the prevention of serial seizures in adult epileptic patients. (1984) (42)
Effect of atenolol, metoprolol, and propranolol on isoproterenol‐induced tremor and tachycardia in normal subjects (1981) (41)
Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. (1982) (39)
A comparison of the acute effect of single doses of vigabatrin and sodium valproate on photosensitivity in epileptic patients (1987) (38)
Relation Between Dosage of Carbamazepine and Concentration in Hair and Plasma Samples From a Compliant Inpatient Epileptic Population (2001) (38)
Rectal absorption of diazepam in epileptic children. (1982) (37)
The Pharmacokinetics of Tiagabine in Healthy Elderly Volunteers and Elderly Patients with Epilepsy (1997) (37)
CONTROLLED TRIAL OF SODIUM VALPROATE IN SEVERE EPILEPSY (1975) (37)
Pharmacokinetics of the hypnotic benzodiazepine, temazepam. (1979) (36)
Drug Treatment of Epilepsy (1976) (35)
Methods of assessment of antiepileptic drugs. (1981) (35)
Phenytoin intoxication induced by sulthiame in epileptic patients (1974) (35)
When should plasma drug levels be monitored? (1979) (33)
Proof of efficacy trials: cross-over versus parallel-group (2001) (33)
Effect of valproate on free plasma phenytoin concentrations. (1984) (33)
Acute effects of intravenous phenytoin on the frequency of inter-ictal spikes in man. (1983) (33)
Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug. (1988) (33)
PHENYTOIN DOSAGE NOMOGRAM (1975) (32)
Steady-state plasma nortriptyline concentrations in epileptic patients. (1975) (32)
The clinical value of serum prolactin measurement in the differential diagnosis of complex partial seizures (1989) (32)
Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients. (1984) (32)
The action of general anaesthetic agents on root responses of the frog isolated spinal cord (1969) (32)
Determination of Vigabatrin in Plasma by Reversed‐Phase High‐Performance Liquid Chromatography (1991) (32)
Should we routinely measure free plasma phenytoin concentration? (1984) (31)
Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction. (1980) (31)
Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability. (1993) (31)
Bioavailability and dissolution of proprietary and generic formulations of phenytoin. (1992) (30)
Single and multiple dose pharmacokinetics of felbamate in the elderly. (2003) (30)
Quality Control in Drug Measurement (1980) (29)
DECREASED SERUM PROTEIN BINDING OF PHENYTOIN IN LATE PREGNANCY (1980) (28)
Pharmacokinetics of lamotrigine (1992) (28)
Rectal diazepam in the treatment of absence status: a pharmacodynamic study (1981) (28)
Comparative Bioavailability of Phenytoin from Generic Formulations in the United Kingdom (1982) (28)
Effect of Meptazinol and Ethanol on Human Psychomotor Performance and Mood Ratings (1984) (27)
Interaction between phenytoin and antacids. (1978) (27)
Anticonvulsant Drugs and Enzyme Induction (1976) (27)
Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration. (1981) (26)
Is phenytoin metabolism dose‐dependent by enzyme saturation or by feedback inhibition? (1978) (25)
Serum protein binding of diazepam and its displacement by valproic acid in vitro. (1981) (25)
Liver enzyme induction by anticonvulsant drugs, and its relationship to disturbed calcium and folic acid metabolism. (1973) (25)
Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients (1975) (25)
The effects of salbutamol and terbutaline on physiological tremor, bronchial tone and heart rate. (1974) (25)
Effect of Drug Therapy on the Metabolism of Phenytoin (1975) (25)
Controlled trial of frusemide as an antiepileptic drug in focal epilepsy. (1976) (24)
Results of a Phenytoin Quality Control Scheme (1975) (24)
Performance of techniques for measurement of therapeutic drugs in serum. A comparison based on external quality assessment data. (1992) (24)
Adrenergic control of tendon jerk reflexes in man (1973) (24)
Effect of Dose Increments on Serum Carbamazepine Concentration in Epileptic Patients (1980) (23)
Serum protein binding of valproic acid and its displacement by palmitic acid in vitro. (1979) (23)
Comparison of the effects of therapeutic doses of meptazinol and a dextropropoxyphene/paracetamol mixture alone and in combination with ethanol on ventilatory function and saccadic eye movements. (1985) (23)
Impact of Generic Substitution of Anticonvulsants on the Treatment of Epilepsy (1997) (23)
Clinical Pharmacokinetics of Antiepileptic Drugs (1985) (23)
The effects of sucralfate upon phenytoin absorption in man. (1985) (23)
Theophylline: biochemical pharmacology and pharmacokinetics. (1979) (22)
Performance of techniques used to detect drugs of abuse in urine: study based on external quality assessment. (1991) (22)
Video games and epileptic seizures—a consensus statement (1994) (21)
Quality Control of Drug Assays (1981) (21)
A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs. (1980) (21)
The effect of frusemide, mexiletine, (+)-propranolol and three benzodiazepine drugs on interictal spike discharges in the electroencephalograms of epileptic patients. (1977) (20)
Mutual Interaction Between Remacemide Hydrochloride and Carbamazepine: Two Drugs with Active Metabolites (1996) (19)
The effect of oral contraceptive steroids and enzyme inducing drugs on sex hormone binding globulin capacity in women [proceedings]. (1980) (19)
Evaluation of Assay Techniques for the Measurement of Antiepileptic Drugs in Serum: A Study Based on External Quality Assurance Measurements (1989) (19)
Drug level monitoring—quantity and quality (1978) (18)
Interpretation of drug levels: relevance of plasma protein binding. (1979) (18)
The influence of elevated plasma hydrocortisone concentrations on antipyrine metabolism in man. (1974) (18)
A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy (2000) (18)
Framework of medical care of epilepsy. (1987) (18)
Rational polypharmacy (1995) (17)
A pragmatic randomised controlled trial of a prompt and reminder card in the care of people with epilepsy. (2002) (16)
Effect of low‐dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects [letter] (1981) (16)
The comparative enzyme-inducing properties of antiepileptic drugs [proceedings]. (1979) (16)
Focal Motor Status Epilepticus Following Treatment with Azlocillin and Cefotaxime (1987) (16)
Toxicity of folic acid. (1971) (16)
The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance. (1985) (16)
The effect of losigamone (AO‐33) on electrical activity and excitatory amino acid release in mouse cortical slices (1997) (15)
Vigabatrin and behaviour disturbances (1990) (15)
Pharmacokinetics of Phenylethylmalonamide (PEMA) in Normal Subjects and in Patients Treated with Antiepileptic Drugs (1982) (15)
The effect of the desglycinyl metabolite of remacemide hydrochloride (FPL 12495AA) and dizocilpine (MK‐801) on endogenous amino acid release from mouse cortex (1995) (15)
Genetic Markers in Epilepsy (1981) (14)
Folate metabolism and problem behaviour in mentally handicapped epileptics. (2008) (14)
QUALITY CONTROL OF DRUG ESTIMATIONS (1975) (14)
Mutual interaction between remacemide hydrochloride and phenytoin (1997) (14)
Inhibition of phenytoin metabolism by other drugs used in epilepsy. (1975) (14)
A Survey of Drugs of Abuse Testing by Clinical Laboratories in the United Kingdom (1990) (14)
A Risk-Benefit Assessment of Vigabatrin in the Treatment of Neurological Disorders (1994) (14)
Microelectrode studies in the frog isolated spinal cord during depression by general anaesthetic agents (1969) (13)
Antidepressant drugs, convulsions and epilepsy. (1983) (13)
Differential effects of alpha-adrenoceptor blockade on essential, physiological and isoprenaline-induced tremor: evidence for a central origin of essential tremor. (1985) (13)
Drug Estimation in the Treatment of Epilepsy (1974) (13)
A comparison of intramuscular meptazinol (100 mg) and papaveretum (20 mg) on human performance studies in healthy male volunteers. (1983) (13)
Effect of antiepileptic drugs on the hypothalamic-pituitary axis. (1981) (13)
Pharmacokinetics of antipyrine in epileptic patients. (1986) (13)
Pharmacokinetic and pharmacodynamic drug interactions during treatment with vigabatrin (1995) (12)
The effects of repeated doses of temazepam and nitrazepam on several measures of human performance (1986) (12)
The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs. (1974) (12)
Acute effect of phenytoin on serum folate concentration. (1971) (11)
Effects of felbamate on veratridine- and K(+)-stimulated release of glutamate from mouse cortex. (1996) (11)
CHRONIC PHENYTOIN THERAPY AND CARBOHYDRATE TOLERANCE (1973) (11)
Comparison of Assay Methods Used to Measure Antiepileptic Drugs in Plasma (1983) (11)
Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man? (1986) (11)
Serum protein binding of phenytoin in women: effect of pregnancy and oral contraceptives. (1982) (11)
Serum protein binding of phenytoin in pregnant women (1981) (10)
Trials in the elderly (2001) (10)
Decreased serum protein binding of diazepam and valproic acid in pregnant women (1981) (10)
Disposition of Anticonvulsants in Childhood (1989) (9)
Spuriously high values of unbound drug fraction in serum as determined by the new ultrafree anticonvulsant drug filters. (1981) (9)
RETROPERITONEAL FIBROSIS ASSOCIATED WTTH TIMOLOL (1983) (9)
New drugs for epilepsy: A rapidly changing scene (1992) (9)
Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects. (1981) (9)
Propranolol and sotalol as antagonists of isoproterenol‐enhanced physiologic tremor (1981) (9)
Serum protein binding of diazepam in maternal and foetal serum during pregnancy. (1982) (9)
Antiepileptic Drug Interactions (1985) (9)
Methods in Clinical Pharmacology—Central Nervous System (1981) (8)
Evidence for both in vivo and in vitro interaction between vigabatrin and alanine transaminase. (2003) (8)
Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly (2004) (8)
Anticonvulsant Therapy, Pharmacological Basis and Practice (1980) (8)
Evaluation of Chromatographic and Kit Immunoassay Techniques for the Measurement of Theophylline in Serum: A Study Based on External Quality Assurance Measurements (1988) (8)
Lack of pharmacokinetic interaction between remacemide hydrochloride and sodium valproate in epileptic patients (1997) (8)
Tremor: an alternative approach for investigating adrenergic mechanisms in thyrotoxicosis? (1985) (7)
Reversal of competitive neuromuscular blockade by RX 67668 in normal volunteers. (1972) (7)
Water intoxication produced by carbamazepine and its reversal by phenytoin [proceedings]. (1980) (7)
MONITORING SERUM-PHENYTOIN (1976) (7)
Effect of diazepam on oculomotor balance. (1974) (7)
Overnight urine specimens for the determination of D-glucaric acid excretion in man. (1979) (7)
Effect of gamma aminobutyric acid on the carbon dioxide rebreathing response of normal subjects: a study using vigabatrin. (1990) (7)
Essential tremor: treatment with beta-adrenoceptor blocking drugs (1984) (6)
Absence of Interaction Between Tiagabine, a New Antiepileptic Drug, and the Benzodiazepine Triazolam (1998) (6)
Standard units for expressing drug concentrations in biological fluids (1983) (6)
Haematological values of epileptic patients entering drug trials. (1988) (6)
Interaction between anticonvulsant drugs and vitamin D. (1970) (6)
Once‐Daily Versus Twice‐Daily Vigabatrin: Is There a Difference? The Results of a Double‐Blind Pilot Study (1999) (6)
Results of a quality control scheme for the assay of theophylline in serum. (1979) (6)
Calcium metabolism in patients with epilepsy. (1970) (6)
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. 1984. (2004) (6)
Evaluation of a New Immunoassay for Determination of Phenytoin and Phenobarbital: Results of a European Collaborative Control Study (1977) (6)
Human cognitive function following binedaline (50 mg and 100 mg) and imipramine (75 mg): Results with a new battery on tests (2004) (6)
THYMOXAMINE AND SPASTICITY (1974) (6)
A survey of caffeine measurements in routine samples submitted for theophylline assay. (1985) (6)
Comparison of Human, Bovine, and Newborn Calf Serum in the Preparation of External Quality Assurance Samples for Therapeutic Drugs (1990) (5)
DRUG INTERACTIONS IN EPILEPSY (1975) (5)
Plasma protein binding interaction between valproic acid and palmitic acid in vitro [proceedings]. (1978) (5)
Metabolic effect of folic acid replacement therapy in folate deficient epileptic patients (1980) (5)
A standardized method for assessing the effect of β-adrenoceptor blocking drugs upon isoprenaline-induced physiological tremor and tachycardia: a test for cardioselectivity? (1981) (5)
Ioglycamide (Biligram) studies in man--plasma binding, renal and biliary excretion studies in jaundiced and anicteric patients. (1978) (5)
New antiepileptic drugs. (1990) (5)
Pharmacokinetics of Phenylethylmalonamide (PEMA) after Oral and Intravenous Administration (1983) (5)
A microcomputer based technique for the assessment of hand tremor in man (1983) (5)
Are serum anticonvulsant levels in people with epilepsy appropriately monitored? (2001) (5)
The efficacy and safety of new antiepileptic drugs. (1991) (5)
Vigabatrin-induced psychosis—management problems (1994) (5)
Bilateral ballistic movements occurring as a late complication of hemispherectomy and responding to sulpiride (1986) (4)
Pharmacokinetics of anticonvul sant drugs (1980) (4)
External Quality Assurance of Tricyclic Antidepressant Measurements in Serum: Eight Years of Progress? (1989) (4)
Clinical practice (2002) (4)
Pheneturide, a more potent liver enzyme inducer in man than phenobarbitone? (1973) (4)
Joint international quality control programme on the determination of antiepileptic drugs (1979) (4)
Calcium homeostasis in mentally handicapped epileptic patients. (2008) (4)
Letter: Phenytoin intoxication caused by sulthiame. (1973) (4)
New inhibitor of acetylcholinesterase with preferential activity at nicotinic sites (1974) (4)
Accuracy and Precision of Gas‐Liquid Chromatographic, High‐Pressure Liquid Chromatographic, and Enzyme Immunoassay Techniques for the Measurement of Theophylline Concentrations in Serum: A Comparison Based on External Quality Assurance Measurements (1984) (4)
Epilepsy Research: Preface (2001) (4)
Interactions with Antiepileptic Drugs (1977) (4)
CLASSICAL RICKETS AND OSTEOMALACIA IN BRITAIN (1976) (4)
Genetic markers in epilepsy: a survey. (1981) (4)
Monitoring free plasma concentrations of phenytoin—a reply (1984) (4)
Stimulation of drug metabolism by folate replacement in folate-deficient epileptic patients [proceedings]. (1980) (3)
Essentials of clinical pharmacology for education and research in developing countries. (1984) (3)
Difference in the central actions of phenytoin and phenobarbitone in man, measured by critical flicker fusion threshold (1973) (3)
Monitoring antiepileptic drug therapy. (1981) (3)
Analysis of assay errors in drug measurements from the Heathcontrol interlaboratory quality assessment schemes. (1984) (3)
Staff Training in the Management of Violence and Aggression: 3. Physical Restraint (2009) (3)
19 – Antiepileptic drugs, pregnancy and the newborn (1983) (3)
Quality control for drug monitoring. (1977) (3)
Staff training in the management of violence and aggression: 1 – SETTING UP A TRAINING SYSTEM (2009) (3)
A method for studying spinal pharmacology in man. (1970) (3)
PHENYTOIN BINDING IN PREGNANCY (1981) (3)
Preliminary assessment of RX 72601, a new anticholinesterase in man: reversal of competitive neuromuscular blockade. (1974) (3)
Folic Acid in Epilepsy (1971) (3)
Benign familial tremor treated with primidone. (1981) (3)
Enzyme induction and folate deficiency. (1972) (3)
Video EEG telemetry using an ambulatory EEG cassette recorder. (1987) (3)
A comparison of phenobarbitone and primidone in the control of seizures in chronic epilepsy [proceedings]. (1979) (2)
α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man. (1974) (2)
Pharmacokinetics of anticonvulsant drugs. (1980) (2)
Bartscontrol: an external quality control scheme for antiepileptic drugs (1979) (2)
Two dimensional immunoelectrophoresis of human serum proteins for the investigation of protein drugs. (1972) (2)
Drug Interactions with Phenytoin (1981) (2)
The pathophysiological basis of drug toxicity. (1980) (2)
Exercise-induced handtremor: apossible test for 132-adrenoceptor selectivity inman? (1986) (2)
Proceedings: Inhibition of phenytoin metabolism by sulthiame. (1973) (2)
Interaction between lithium and carbamazepine. (1980) (2)
Letter: Chronic phenytoin therapy and carbohydrate tolerance. (1973) (2)
Letter: "Anticonvulsant action" of vitamin D in epileptic patients. (1974) (2)
Interlaboratory variability of valproic acid determinations. (1977) (2)
METOPROLOL IN ESSENTIAL TREMOR (1981) (2)
Clinical practice: antimalarial prophylaxis in patients with epilepsy [corrected]. (2002) (2)
Staff Training in the Management of Violence and Aggression (2009) (2)
Comparison of nonisotopic and radioimmunoassay techniques for digoxin: a study based on external quality assurance measurements. (1989) (2)
Metoprolol andpropranolol inessential tremor: adouble-blind, controlled study (1981) (2)
Tiagabine hydrochloride safety and efficacy as adjunctive treatment for complex partial seizures (1991) (2)
Letter: Vitamin D deficiency in rheumatoid arthritis. (1975) (1)
Proceedings: Effects of salbutamol and terbutaline on physiological tremor in man. (1973) (1)
PHARMACOLOGY AND THE MOLE (1978) (1)
Drug interactions and lethal drug combinations (1975) (1)
Points from Letters: Quality Control for Serum Phenytoin (1972) (1)
Proof of principle trials: EEG surrogate endpoints (2001) (1)
Methods in clinical pharmacology (1980) (1)
Preface (2001) (1)
Treatment for teenagers with epilepsy (1985) (1)
Antiepileptic Drugs (1985) (1)
An enhanced serum prolactin response to TRH in the presence of GABA transaminase inhibition. (1987) (1)
Central Nervous System (1981) (1)
The risks and benefits of current and new anti-epileptic drugs. (1988) (1)
Erratum to: Clinical Pharmacokinetics of Phenytoin: Clinical Pharmacokinetics of Phenytoin: Correction to previously published dosage nomogram (1980) (1)
Efficacy of tiagabine (Gabitril) in all partial seizure types (1997) (1)
Influence of methodological factors in determining the accuracy and precision of measurements of tricyclic antidepressant drug concentrations in serum. (1986) (1)
A study of inter-reviewer reliability of attacks recorded on ambulatory EEG. (1989) (1)
Letter: Classical rickets and osteomalacia in Britain. (1970) (1)
EMPLOYMENT OPPORTUNITIES: for people with mental handicaps (2009) (1)
Drugs for epilepsy. (2020) (0)
Erratum to “Clinical practice: antimalarial prophylaxis in patients with epilepsy” [Epilepsy Res. 51 (2002) 1–4] (2003) (0)
Anticonvulsant hypocalcaemia. (1972) (0)
A Controlled Trial of Cinromide (1983) (0)
Metabolism andurinary excretion of5-amino salicylic acid inhealthy volunteers whengivenintravenously or released forabsorption atdifferent sites inthe gastrointestinal tract (1987) (0)
General discussion (2001) (0)
Subject Index Vol. 32, 1992 (1992) (0)
A clinical trial ofsingle doserectal andoral administration ofdiazepam fortheprevention of serial seizures inadult epileptic patients (1984) (0)
Rectal absorption ofdiazepam inepileptic children (1982) (0)
The ultrafree drug filters: need for closer evaluation. (1981) (0)
Book Review: Clinical Management of Seizures: A Guide for the Physician (1977) (0)
Abstracts of poster presentations (1993) (0)
Alterations of drug toxicity in neuropsychiatric disease states. (1984) (0)
Phenobarbitone and epilepsy. (1980) (0)
Patient with circulating antibodies to alpha-interferon. (1981) (0)
The framework of medical care for epilepsy. (1987) (0)
CLINICAL PHARMACOKINETICS OF PHENYTOIN (1977) (0)
THE PREVENTION OF POST-MENOPAUSAL BONE LOSS WITH A NEW FORMULATION OF LOW DOSE MICRONISED MEDROXYPROGESTERONE ACETATE AND 17-BETA OESTRADIOL (1998) (0)
2537 – EFFECT OF SINGLE DOSES OF SODIUM VALPROATE ON SERUM PHENYTOIN CONCENTRATION AND PROTEIN BINDING IN VIVO (1978) (0)
Characteristics of the Welsh juvenile myoclonic epilepsy cohort. (1995) (0)
Developments in drug therapy. (1973) (0)
Drug treatment of spasticity. (1970) (0)
In defense of polytherapy (1995) (0)
Effects of sodium valproate on the serum protein binding of phenytoin, and on liver enzyme activity. (1980) (0)
Clinical Relevance of Serum Drug Level Monitoring, with Particular Reference to Phenytoin (1979) (0)
Management of epilepsy in the mentally handicapped (2009) (0)
Drug interactions and lethal drug combinations (1975) (0)
Is EUROQOL a good summary measure of the quality of life of people with epilepsy (1999) (0)
Sensible prescribing. XI.--Juvenile and adult epilepsy. (1975) (0)
Variability in Human Drug Response (1974) (0)
Antiepileptic Drugs: Quantitative Analysis and Interpretation (1979) (0)
BIOAVAILABILITYOFDIAZEPAM AFTERINTRAVENOUS, ORAL AND RECTALADMINISTRATIONINADULT EPILEPTIC PATIENTS (1982) (0)
Preface (1991) (0)
Book Review: Anticonvulsant Drugs (1974) (0)
Genetic systems in epileptic patients. (1973) (0)
Clinical management of syncope and seizures in GUM clinics (1997) (0)
PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY (1973) (0)
Drugs for epilepsy. (1995) (0)
Book Review: Variability in Human Drug Response (1974) (0)
New antiepiletic drugs (1993) (0)
With commentary (1981) (0)
Drug treatment of spasticity. (1975) (0)
Juvenile myoclonic epilepsy: Authors' reply (1992) (0)
Bio-availability and its clinical implications. (1975) (0)
A pharmacodynamic evaluation ofmidazolam asan antiepileptic compound (1986) (0)
Clinical Research Lamotrigine-Associated Rash: RisWBenefit Considerations in Adults and Children (1999) (0)
Quality control of drug assays. (1979) (0)
decrease inserum phenytoin concentration doesnotinvolve achange inphenytoin bioavailability (1993) (0)

This paper list is powered by the following services:

A. R. Richens's Academic­Influence.com Rankings

A. R. Richens's Degrees

Why Is A. R. Richens Influential?

A. R. Richens's Published Works

Published Works

A. R. Richens's AcademicInfluence.com Rankings